In a remarkable medical breakthrough, doctors have successfully used stem cells to treat a debilitating eye condition that ...

Hannah was denied the transplant locally, so she sought experts at New York City’s Memorial Sloan Kettering Cancer Center, ...

Hematopoietic stem cell transplant (HSCT) after first complete remission appears more effective than non-HSCT consolidation in older patients with AML.

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

Thanks to Joanna from Poland, I have no measurable leukemia. Getting college-age kids to join the bone-marrow donor registry ...

IN8bio will present updated clinical trial results from INB-200 in a Plenary Oral Presentation at the Society for Neuro-Oncology (SNO) in November 2024. A poster presentation updating patient data ...

A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...

Life was good for Betsy Ehrenberg. It was 2017, and she was 68, a partner at Boston law firm Pyle Rome Ehrenberg PC. She represented unions in collective bargaining matters and workers who’d ...

Researchers found that neural crest stem cells are uniquely capable of reprogramming, challenging current reprogramming ...

On Sunday, thousands of runners will step up to the line at the B.A.A.'s Boston Half Marathon. But few will have the motivation that an Attleboro mom will carry with her every step of the way.

Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.

The agency reviewed data from the FELIX trial, in which 63 percent of patients achieved a complete remission on the cell therapy at any time point.